Evidence map›Paper›PMID 34834051›Full record

ArticleMolecules (Basel, Switzerland)2021

Don't Overweight Weights: Evaluation of Weighting Strategies for Multi-Task Bioactivity Classification Models.

Lina Humbeck, Tobias Morawietz, Noe Sturm, Adam Zalewski, Simon Harnqvist, Wouter Heyndrickx, Matthew Holmes, Bernd Beck

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lina HumbeckMedicinal Chemistry Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach an der Riss, Germany.ORCID 0000-0003-3151-9158
Tobias MorawietzBayer AG, Pharmaceuticals, R&D, Digital Technologies, Computational Molecular Design, 42096 Wuppertal, Germany.ORCID 0000-0002-9385-8721
Noe SturmNovartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.
Adam ZalewskiAmgen Research (Munich) GmbH, Staffelseestraße 2, 81477 Munich, Germany.ORCID 0000-0002-8341-9565
Simon HarnqvistComputational Sciences, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK.ORCID 0000-0002-6315-5531
Wouter HeyndrickxJanssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse, Belgium.
Matthew HolmesComputational Sciences, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK.
Bernd BeckMedicinal Chemistry Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach an der Riss, Germany.

Funding

European Union Horizon 2020Innovative Medicines Initiative 831472
6 · The paper itself

Abstract

Machine learning models predicting the bioactivity of chemical compounds belong nowadays to the standard tools of cheminformaticians and computational medicinal chemists. Multi-task and federated learning are promising machine learning approaches that allow privacy-preserving usage of large amounts of data from diverse sources, which is crucial for achieving good generalization and high-performance results. Using large, real world data sets from six pharmaceutical companies, here we investigate different strategies for averaging weighted task loss functions to train multi-task bioactivity classification models. The weighting strategies shall be suitable for federated learning and ensure that learning efforts are well distributed even if data are diverse. Comparing several approaches using weights that depend on the number of sub-tasks per assay, task size, and class balance, respectively, we find that a simple sub-task weighting approach leads to robust model performance for all investigated data sets and is especially suited for federated learning.

Indexed as

Machine LearningDrug DesignDrug DiscoveryHumansSmall Molecule LibrariesSmall Molecule Librariesclassificationdrug designfederatedmachine learningMELLODDYmulti-task learningsmall molecule drug discoveryweighting

Identifiers

PMID34834051
PMCPMC8620420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.